Merck Clarifies ClinicalTrials.gov Postings; Listed As Sponsor Of 13 Studies
Executive Summary
Merck is enrolling patients in three type 2 diabetes trials - including pioglitazone and metformin add-on studies - for a late-stage investigational drug, according to the company's recently updated postings on the HHS-sponsored website ClinicalTrials.gov
You may also be interested in...
Sen. Baucus Urges More Comparative Research At Vioxx Hearing
The Vioxx withdrawal demonstrates the need for more comparative research on drugs, Sen. Max Baucus (D-N.M.) suggested in his questioning of witnesses at the Senate Finance Committee's hearing on Merck's withdrawal of the COX-2 inhibitor
Sen. Baucus Urges More Comparative Research At Vioxx Hearing
The Vioxx withdrawal demonstrates the need for more comparative research on drugs, Sen. Max Baucus (D-N.M.) suggested in his questioning of witnesses at the Senate Finance Committee's hearing on Merck's withdrawal of the COX-2 inhibitor
Antidepressant Manufacturer Trial Information Requested By Senate Cmte.
Antidepressant manufacturers have until Aug. 27 to submit information about pediatric clinical trials to the Senate Finance Committee